AARD
Aardvark Therapeutics
$1.44
−$0.07 (−4.64%)Oct 29, 2026
Key metrics
The numbers that frame AARD today
- Market cap
- $31.51M
- ROIC
- -163.9%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.93
- 52wk High
- $16.60
Growth
Revenue and earnings trend for AARD
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AARD
Is Aardvark Therapeutics a good buy?
No. Aardvark Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup.
What is the market capitalization of AARD?
Aardvark Therapeutics's market capitalization is $31.51M.
What is the 52-week high for AARD stock?
The 52-week high for Aardvark Therapeutics is $16.60. The current close of $1.44 is 91.3% below that high.
What is the 52-week low for AARD stock?
The 52-week low for Aardvark Therapeutics is $0.93. The current close of $1.44 is 54.8% above that low.
Does AARD stock pay dividends?
Aardvark Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AARD?
Aardvark Therapeutics's Debt / Equity ratio is 0.01.